Search AI Products and News

Welcome to the 【AI Daily】 column! This is your guide to exploring the world of artificial intelligence every day. Here we bring you hot content in the AI field, focusing on developers to help you gain insights into technical trends and understand innovative AI product applications. Fresh AI products click to learn more: https://top.aibase.com/1. The world's first Office intelligent agent APP! Kunlun Wonderworks TianGong Super Intelligent APP launched by Kunlun WonderWorks Group.

Recently, Google has once again stirred the artificial intelligence world by announcing the release of three new variants of the Gemma model: MedGemma, SignGemma, and DolphinGemma. These models are targeted at the healthcare, sign language translation, and dolphin communication fields respectively, showcasing the immense potential of AI technology across domains. Below, AIbase will detail the highlights and application prospects of these three models. MedGemma: Revolutionizing Medical AI, Enabling Precise Diagnosis and Treatment...

Researchers have created a computer worm named 'Morris II' that can manipulate generative artificial intelligence systems to perform malicious tasks by constantly replicating and infecting new systems, spreading and executing destructive actions specifically targeting the generative AI ecosystem and agent interconnect networks. The researchers warn that such attacks could impact fields like smartphones and automobiles.

Harvard Medical School and the University of Oxford have collaborated to develop the EVEscape AI tool, which accurately predicts virus variants, including COVID-19. This tool has the capability to predict signs of viral mutations and the effectiveness of antibody therapies, and it can also forecast mutation trajectories for viruses such as HIV and influenza. EVEscape combines generative models with detailed biological information to make early predictions about virus variants. The research team releases a list of the most likely new virus variants every two weeks, broadening the tool's coverage to address more unstudied pathogens.